2,2-Difluorodeoxyuridine (dFdU) is the main metabolite of Gemcitabine (HY-17026). 2,2-Difluorodeoxyuridine causes a concentration- and schedule- dependent radiosensitising effect in vitro. 2,2-Difluorodeoxyuridine arrests cell cycle at the early S phase and induces apoptosis in cancer cells[1][2][3].
Molecular Weight:
264.18
Purity:
99.87
CAS Number:
[114248-23-6]
Formula:
C9H10F2N2O5
Target:
Apoptosis,Drug Metabolite
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted